Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Thamm

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Veterinary and Comparative Oncology|September 17, 2009
Interactions between radiation therapy and immunotherapy: the best of two worlds?D H Thamm
Veterinary and Comparative Oncology|August 18, 2015
Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocolK Curran, D H Thamm
American Journal of Veterinary Research|April 2, 1998
Preclinical evaluation of a sterically stabilized liposome-encapsulated cisplatin in clinically normal catsD H Thamm, D M Vail
Veterinary and Comparative Oncology|June 29, 2010
Interleukin-11 receptor alpha is expressed on canine osteosarcomaJ L Sottnik, D H Thamm
Journal of Veterinary Internal Medicine|March 27, 2010
Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transportersD L Gustafson, D H Thamm
Journal of Veterinary Internal Medicine|February 7, 2012
Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancerL Mitchell, D H Thamm, B J Biller
Journal of Veterinary Internal Medicine|September 28, 1999
Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997)D H Thamm, E A Mauldin, D M Vail
Veterinary and Comparative Oncology|January 13, 2012
Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcomaC F Saba, D M Vail, D H Thamm
Veterinary and Comparative Oncology|August 10, 2010
Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled studyJ C Lori, T J Stein, D H Thamm
Veterinary and Comparative Oncology|July 4, 2012
Development of a limited-sampling model for prediction of doxorubicin exposure in dogsL A Wittenburg, D H Thamm, D L Gustafson
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Veterinary and Comparative Oncology|September 17, 2009
Interactions between radiation therapy and immunotherapy: the best of two worlds?D H Thamm
Veterinary and Comparative Oncology|August 18, 2015
Retrospective analysis for treatment of naïve canine multicentric lymphoma with a 15-week, maintenance-free CHOP protocolK Curran, D H Thamm
American Journal of Veterinary Research|April 2, 1998
Preclinical evaluation of a sterically stabilized liposome-encapsulated cisplatin in clinically normal catsD H Thamm, D M Vail
Veterinary and Comparative Oncology|June 29, 2010
Interleukin-11 receptor alpha is expressed on canine osteosarcomaJ L Sottnik, D H Thamm
Journal of Veterinary Internal Medicine|March 27, 2010
Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transportersD L Gustafson, D H Thamm
Journal of Veterinary Internal Medicine|February 7, 2012
Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancerL Mitchell, D H Thamm, B J Biller
Journal of Veterinary Internal Medicine|September 28, 1999
Prednisone and vinblastine chemotherapy for canine mast cell tumor--41 cases (1992-1997)D H Thamm, E A Mauldin, D M Vail
Veterinary and Comparative Oncology|January 13, 2012
Phase II clinical evaluation of lomustine chemotherapy for feline vaccine-associated sarcomaC F Saba, D M Vail, D H Thamm
Veterinary and Comparative Oncology|August 10, 2010
Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled studyJ C Lori, T J Stein, D H Thamm
Veterinary and Comparative Oncology|July 4, 2012
Development of a limited-sampling model for prediction of doxorubicin exposure in dogsL A Wittenburg, D H Thamm, D L Gustafson
Pageof 6